Cargando…

Acceleration training for managing nonalcoholic fatty liver disease: a pilot study

BACKGROUND: While aerobic training is generally recommended as therapeutic exercise in guidelines, the effectiveness of resistance training has recently been reported in the management of nonalcoholic fatty liver disease (NAFLD). Acceleration training (AT) is a new training method that provides a ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Sechang, Shida, Takashi, Sawai, Akemi, Maruyama, Tsuyoshi, Eguchi, Kiyoshi, Isobe, Tomonori, Okamoto, Yoshikazu, Someya, Noriko, Tanaka, Kiyoji, Arai, Emi, Tozawa, Akiko, Shoda, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230176/
https://www.ncbi.nlm.nih.gov/pubmed/25404857
http://dx.doi.org/10.2147/TCRM.S68322
_version_ 1782344222147346432
author Oh, Sechang
Shida, Takashi
Sawai, Akemi
Maruyama, Tsuyoshi
Eguchi, Kiyoshi
Isobe, Tomonori
Okamoto, Yoshikazu
Someya, Noriko
Tanaka, Kiyoji
Arai, Emi
Tozawa, Akiko
Shoda, Junichi
author_facet Oh, Sechang
Shida, Takashi
Sawai, Akemi
Maruyama, Tsuyoshi
Eguchi, Kiyoshi
Isobe, Tomonori
Okamoto, Yoshikazu
Someya, Noriko
Tanaka, Kiyoji
Arai, Emi
Tozawa, Akiko
Shoda, Junichi
author_sort Oh, Sechang
collection PubMed
description BACKGROUND: While aerobic training is generally recommended as therapeutic exercise in guidelines, the effectiveness of resistance training has recently been reported in the management of nonalcoholic fatty liver disease (NAFLD). Acceleration training (AT) is a new training method that provides a physical stimulation effect on skeletal muscles by increasing gravitational acceleration with vibration. AT has recently been indicated as a component of medicine. In this study, we evaluated the effectiveness of AT in the management of NAFLD in obese subjects. METHODS: A total of 18 obese patients with NAFLD who had no improvement in liver function test abnormalities and/or steatosis grade after 12 weeks of lifestyle counseling were enrolled in an AT program. These patients attended a 20-minute session of AT twice a week for 12 consecutive weeks. RESULTS: During the AT program, the NAFLD patients showed a modest increase in the strength (+12.6%) and cross-sectional area (+3.1%) of the quadriceps, coupled with a significant reduction in intramyocellular lipids (−26.4%). Notably, they showed a modest reduction in body weight (−1.9%), abdominal visceral fat area (−3.4%), and hepatic fat content (−8.7%), coupled with a significant reduction in levels of aminotransferase (−15.7%), γ-glutamyltransferase (−14.4%), leptin (−9.7%), interleukin-6 (−26.8%), and tumor necrosis factor-α (−17.9%), and a significant increase of adiponectin (+8.7%). On a health-related quality of life survey, the patients showed an improvement in physical functioning (+17.3%), physical role (+9.7%), general health (+22.1), and social functioning (+6.0%). CONCLUSION: AT reduced hepatic and intramyocellular fat contents and ameliorated liver function test abnormalities in obese patients with NAFLD, which was coupled with improved physical function and body adiposity. AT is clinically beneficial for the management of NAFLD.
format Online
Article
Text
id pubmed-4230176
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42301762014-11-17 Acceleration training for managing nonalcoholic fatty liver disease: a pilot study Oh, Sechang Shida, Takashi Sawai, Akemi Maruyama, Tsuyoshi Eguchi, Kiyoshi Isobe, Tomonori Okamoto, Yoshikazu Someya, Noriko Tanaka, Kiyoji Arai, Emi Tozawa, Akiko Shoda, Junichi Ther Clin Risk Manag Original Research BACKGROUND: While aerobic training is generally recommended as therapeutic exercise in guidelines, the effectiveness of resistance training has recently been reported in the management of nonalcoholic fatty liver disease (NAFLD). Acceleration training (AT) is a new training method that provides a physical stimulation effect on skeletal muscles by increasing gravitational acceleration with vibration. AT has recently been indicated as a component of medicine. In this study, we evaluated the effectiveness of AT in the management of NAFLD in obese subjects. METHODS: A total of 18 obese patients with NAFLD who had no improvement in liver function test abnormalities and/or steatosis grade after 12 weeks of lifestyle counseling were enrolled in an AT program. These patients attended a 20-minute session of AT twice a week for 12 consecutive weeks. RESULTS: During the AT program, the NAFLD patients showed a modest increase in the strength (+12.6%) and cross-sectional area (+3.1%) of the quadriceps, coupled with a significant reduction in intramyocellular lipids (−26.4%). Notably, they showed a modest reduction in body weight (−1.9%), abdominal visceral fat area (−3.4%), and hepatic fat content (−8.7%), coupled with a significant reduction in levels of aminotransferase (−15.7%), γ-glutamyltransferase (−14.4%), leptin (−9.7%), interleukin-6 (−26.8%), and tumor necrosis factor-α (−17.9%), and a significant increase of adiponectin (+8.7%). On a health-related quality of life survey, the patients showed an improvement in physical functioning (+17.3%), physical role (+9.7%), general health (+22.1), and social functioning (+6.0%). CONCLUSION: AT reduced hepatic and intramyocellular fat contents and ameliorated liver function test abnormalities in obese patients with NAFLD, which was coupled with improved physical function and body adiposity. AT is clinically beneficial for the management of NAFLD. Dove Medical Press 2014-11-07 /pmc/articles/PMC4230176/ /pubmed/25404857 http://dx.doi.org/10.2147/TCRM.S68322 Text en © 2014 Oh et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Oh, Sechang
Shida, Takashi
Sawai, Akemi
Maruyama, Tsuyoshi
Eguchi, Kiyoshi
Isobe, Tomonori
Okamoto, Yoshikazu
Someya, Noriko
Tanaka, Kiyoji
Arai, Emi
Tozawa, Akiko
Shoda, Junichi
Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title_full Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title_fullStr Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title_full_unstemmed Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title_short Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
title_sort acceleration training for managing nonalcoholic fatty liver disease: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230176/
https://www.ncbi.nlm.nih.gov/pubmed/25404857
http://dx.doi.org/10.2147/TCRM.S68322
work_keys_str_mv AT ohsechang accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT shidatakashi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT sawaiakemi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT maruyamatsuyoshi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT eguchikiyoshi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT isobetomonori accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT okamotoyoshikazu accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT someyanoriko accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT tanakakiyoji accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT araiemi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT tozawaakiko accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy
AT shodajunichi accelerationtrainingformanagingnonalcoholicfattyliverdiseaseapilotstudy